Moreover, DLGAP5 promotes the proliferation and invasion of hepatocellular carcinoma (HCC) (Tang et al., 2021), bladder cancer (BLCA) (Zhou et al., 2024), and breast cancer (Li et al., 2023). The gene discussed is DLGAP5; the disease is urinary bladder carcinoma.